| Chittenango Physical Therapy, P.c. | |
|
1398 Route 5 W, Chittenango, NY 13037 | |
| (315) 510-3372 | |
| (315) 510-3688 |
| Full Name | Chittenango Physical Therapy, P.c. |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 1398 Route 5 W, Chittenango, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477782589 | NPI | - | NPPES |
| 6312360001 | Other | MEDICARE DME | |
| J100000252 | Other | NY | PTAN |
| Provider Name | Meredith C Albert |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1376868257 PECOS PAC ID: 3577554344 Enrollment ID: I20040520000641 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Timothy Francisco |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1568435105 PECOS PAC ID: 4789663899 Enrollment ID: I20040714000231 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Linda B Harrington |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558323287 PECOS PAC ID: 3577516053 Enrollment ID: I20050224000364 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Daniel G Kingsley |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1619940756 PECOS PAC ID: 8820140486 Enrollment ID: I20090714000210 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Alyssa C Kurtzner Shute |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407124639 PECOS PAC ID: 1153598776 Enrollment ID: I20120123000856 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Christopher Anthony Farruggio |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1376942268 PECOS PAC ID: 2264753896 Enrollment ID: I20150608000636 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Samantha G Lawrence |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1902205891 PECOS PAC ID: 1759602394 Enrollment ID: I20150608001115 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Maria Thannhauser |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1679183248 PECOS PAC ID: 1355758558 Enrollment ID: I20210407000251 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Matthew Watson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1780357590 PECOS PAC ID: 5597131334 Enrollment ID: I20221019000187 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Cheryl A Pavlov-shapiro |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1174976278 PECOS PAC ID: 6800262684 Enrollment ID: I20221019001534 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Provider Name | Liam Traynor |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1457022659 PECOS PAC ID: 0749688547 Enrollment ID: I20221020002129 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chittenango Physical Therapy, P.c. 1398 Route 5 W, Chittenango, NY 13037 Ph: (315) 510-3372 | Chittenango Physical Therapy, P.c. 1398 Route 5 W, Chittenango, NY 13037 Ph: (315) 510-3372 |
News Archive
Coronary artery bypass grafting surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.
Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Researchers have known for a decade that the p53 tumor suppressor gene is important for killing cells as they proliferate under low-oxygen conditions inside tumors.
New three-dimensional imaging of the human placenta has been developed to help understand the reasons for fetal growth restriction - a condition which affects thousands in the UK alone.
› Verified 7 days ago
Sean Laubenstein, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3198 Route 5 West, Chittenango, NY 13037 Phone: 315-510-3372 Fax: 315-510-3688 | |
Mrs. Cheryl A Pavlov-shapiro, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1398 State Route 5, Chittenango, NY 13037 Phone: 315-510-3372 Fax: 315-510-3688 | |
Meredith Corbett Albert, PT,CSCS,MDT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1398 Route 5 West, Chittenango, NY 13037 Phone: 315-510-3372 Fax: 315-510-3688 | |
Christopher Farruggio, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1398 Route 5 W, Chittenango, NY 13037 Phone: 315-510-3372 Fax: 315-510-3688 | |
Zachary Rosado, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1398 State Route 5, Chittenango, NY 13037 Phone: 315-510-3372 Fax: 315-510-3688 | |
Linda B Harrington, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1398 State Route 5, Chittenango, NY 13037 Phone: 315-510-3372 Fax: 315-510-3688 |